Robotic surgery
has been progressively used for gastrointestinal disease sites, mainly for
cancers of the rectum, stomach, pancreas and esophagus. Gastrointestinal
surgery is a cure for diseases of the parts of the body concerned in digestion.
This contains the esophagus, small intestine, large intestine, stomach, and
rectum. It also includes the gallbladder, liver and pancreas. Pancreas surgery
is defined as pancreaticoduodenectomy, total pancreatectomy, and distal
pancreatic resection. The surgery eliminates the cancerous or noncancerous
expansion or damaged part of the body, for instance the intestine. It may also
be used in fixing a problem such as hernia (a hole or weak mark in the wall of
the abdomen). In addition, small surgical procedures are for screening &
diagnosing problems of the digestive system. The rapid dispersion of new
technologies in surgery, together with high potential of both patients and the
mass media, has led to numerous gastrointestinal procedures being advanced by the
robots.
According to study,
“Global Robotic Gastrointestinal
Surgery Market 2016-2025: Market Size, Share, Forecast and Strategy” some of the major companies
that are currently operating in the global robotic gastrointestinal surgery
market are AVRA Surgical Robotics, Inc., Medtronic Inc., Intuitive Surgical, Simbionix
USA Corp., NovaTract Surgical, Inc., TransEnterix, Inc., Titan Medical.
Based on the
product & services, global robotic gastrointestinal surgery market is
segmented into instrument & accessories, robotic systems and system
services. Based on procedure, market is segmented into rectopexy (for pelvic or
rectal organ prolapsed), Barrett’s esophagus, achalasia, swallowing disorders, hernia
repair, inflammatory bowel disorders, fecal incontinence, Gastroesophageal
Reflux Disease (GERD), pancreatobiliary disorders, diverticulosis &
diverticulitis, gastroparesis, functional bowel disorders, celiac disease, gastrointestinal
bleeding, colectomy (removal of large intestine mainly due to cancer), colon
polyps, gastrectomy (removal of all or part of stomach) and lower anterior
resection etc. Based on equipment type, market is segmented into navigation
systems, robot machines, planners & simulators and other equipments. Based
on performed operations market is segmented into nissen fundoplication,
cholecystectomy and heller myotomy etc.
Some of the major
benefits associated are less blood loss, less pain, shorter hospital stay,
faster recovery, lower risk of unwanted side effects, quicker return to daily
activities and smaller scars etc. Some of the other major drawbacks include accurate
lymphadenectomy, anastomotic reconstructions, and vascular sutures.
The global
robotic gastrointestinal surgery is driven by increasing population, followed
by increasing disposable income, growing innovative technologies and rising
illness. Apart from advantages, some of the major limitations are high costs of
robotic surgery contrast to laparoscopic & traditional surgery, followed by
the rising learning curve and longer operation times like organizational &
setup troubles etc.
Technological
advancement of the robotic surgery is expected continue due to smarter and efficient
assistive tools & the devices meeting the requirements of gastrointestinal
surgery procedures across the world. The current open gastrointestinal
surgeries and the procedures which can be replaced principally by robotic
minimally include invasive surgery (RMIS). It is estimated that the more
gastrointestinal surgery procedures to be commenced with at least some considerable
features of the surgical robotics due to fast adoption of the advanced RMIS
technology in clinical centers and hospitals. It is also expected that the
global robotic gastrointestinal surgery market to reach at US $1.4 billion, by
2025.
To know more, click on the link below:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
